Loomis, Sayles & Company
OME

Loomis, Sayles & Company’s Omega Protein OME Stock Holding History

Loomis, Sayles & Company’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-318
Closed -$5K – 987
2017
Q3 		$5K Sell
318
-487
-60% -$7.92K ﹤0.01% 848
2017
Q2 		$14K Hold
805
– – ﹤0.01% 785
2017
Q1 		$16K Buy
805
+187
+30% +$4.36K ﹤0.01% 787
2016
Q4 		$15K Buy
+618
New +$14.6K ﹤0.01% 815

Loomis, Sayles & Company's OME Position: Q4 2017 in Review

Loomis, Sayles & Company sold out of Omega Protein (OME) in Q4 2017, closing a stake of 318 shares — an estimated $5K sold.

Loomis, Sayles & Company first reported a position in OME in Q4 2016 and held it in 4 quarters. The position peaked at $16K in Q1 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • Loomis, Sayles & Company reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • Loomis, Sayles & Company sold 318 Omega Protein shares in Q4 2017, an estimated $5K.
  • Loomis, Sayles & Company first reported a position in Omega Protein in Q4 2016 and held it in 4 quarters.
  • Loomis, Sayles & Company's Omega Protein position peaked at $16K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Loomis, Sayles & Company's 13F filing for Q4 2017, filed 14 Feb 2018.